Evidence map›Paper›PMID 42412822›Full record

ArticleBioinformatics (Oxford, England)2026

MiRformer: a dual-transformer-encoder framework for predicting microRNA-mRNA interactions from paired sequences.

Jiayao Gu, Can Chen, Yue Li

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jiayao GuSchool of Computer Science, McGill University, Montréal, QC, H3A 0G4, Canada.
Can ChenMila-Quebéc AI Institute, Montréal, QC, H2S 3H1, Canada.
Yue LiSchool of Computer Science, McGill University, Montréal, QC, H3A 0G4, Canada.ORCID 0000-0003-3844-4865

Funding

DNA2RNA CIHR PJT-540722DNA2RNA CRC-2021-00547
6 · The paper itself

Abstract

motivationMicroRNAs (miRNAs) regulate gene expression by binding to target messenger RNAs (mRNAs), inducing translational repression or mRNA degradation. Accurate prediction of miRNA-mRNA interactions and precise localization of binding and cleavage sites are critical for understanding post-transcriptional regulation and for enabling RNA therapeutics. Existing computational methods often rely on handcrafted or indirect features, scale poorly to kilobase-long mRNA sequences, or provide limited interpretability.

resultsWe present MiRformer, a transformer-based framework that jointly predicts miRNA-mRNA interactions and localizes miRNA binding and cleavage sites directly from raw sequence pairs. MiRformer employs a dual-transformer encoder architecture for miRNA and mRNA sequences and incorporates a sliding-window attention mechanism to efficiently model kilobase-long mRNA contexts while preserving nucleotide-level resolution. Across multiple benchmrks, MiRformer achieves state-of-the-art performance on interaction prediction, binding-site localization, and cleavage-site identification from experimental Human Degradome-seq data. Beyond accuracy, MiRformer provides strong interpretability: attention patterns consistently highlight miRNA seed regions within 500-nt mRNA windows, revealing clear and biologically meaningful interaction signals. When applied to jointly infer binding and cleavage sites across 13k miRNA-mRNA pairs, predicted sites frequently co-localize, supporting a miRNA-mediated degradation mechanism. AVAILABILITY AND IMPLEMENTATION: Python code and datasets are publicly available at https://github.com/li-lab-mcgill/miRformer.

Indexed as

Computational BiologyMicroRNAsRNA, MessengerSequence Analysis, RNASoftwareBinding SitesHumansMicroRNAsRNA, Messenger

Identifiers

PMID42412822
PMCPMC13340221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.